ArticleInternational journal of clinical and experimental medicine2015

Lack of association between XPC Lys939Gln polymorphism and prostate cancer risk: an updated meta-analysis based on 3039 cases and 3253 controls.

Haoran Wu et al.PubMed ↗Full text ↗

No numbers read from the abstract.